392 related articles for article (PubMed ID: 23684364)
21. Effect of a Recombinant Human Soluble Thrombomodulin on Baseline Coagulation Biomarker Levels and Mortality Outcome in Patients With Sepsis-Associated Coagulopathy.
Levi M; Vincent JL; Tanaka K; Radford AH; Kayanoki T; Fineberg DA; Hoppensteadt D; Fareed J
Crit Care Med; 2020 Aug; 48(8):1140-1147. PubMed ID: 32697484
[TBL] [Abstract][Full Text] [Related]
22. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
Wada H; Mori Y; Shimura M; Hiyoyama K; Ioka M; Nakasaki T; Nishikawa M; Nakano M; Kumeda K; Kaneko T; Nakamura S; Shiku H
Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
[TBL] [Abstract][Full Text] [Related]
23. The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation.
Gando S; Hayakawa M; Sawamura A; Hoshino H; Oshiro A; Kubota N; Jesmin S
Thromb Res; 2007; 121(1):67-73. PubMed ID: 17397908
[TBL] [Abstract][Full Text] [Related]
24. Relationship between disseminated intravascular coagulation and levels of plasma thrombinogen segment 1+2, D-dimer, and thrombomodulin in patients with multiple injuries.
Zhu YJ; Huang XK
Chin J Traumatol; 2009 Aug; 12(4):203-9. PubMed ID: 19635212
[TBL] [Abstract][Full Text] [Related]
25. Posttrauma coagulation and fibrinolysis.
Gando S; Tedo I; Kubota M
Crit Care Med; 1992 May; 20(5):594-600. PubMed ID: 1533358
[TBL] [Abstract][Full Text] [Related]
26. Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome.
Gando S; Kameue T; Nanzaki S; Hayakawa T; Nakanishi Y
Crit Care Med; 1997 Nov; 25(11):1820-6. PubMed ID: 9366764
[TBL] [Abstract][Full Text] [Related]
27. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
Nishiyama T; Kohno Y; Koishi K
Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
[TBL] [Abstract][Full Text] [Related]
28. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
[TBL] [Abstract][Full Text] [Related]
29. Phenotypes of Disseminated Intravascular Coagulation.
Wada T; Gando S
Thromb Haemost; 2024 Mar; 124(3):181-191. PubMed ID: 37657485
[TBL] [Abstract][Full Text] [Related]
30. Thrombin generation in trauma patients.
Dunbar NM; Chandler WL
Transfusion; 2009 Dec; 49(12):2652-60. PubMed ID: 19682336
[TBL] [Abstract][Full Text] [Related]
31. Procoagulant activity in patients with isolated severe head trauma.
Scherer RU; Spangenberg P
Crit Care Med; 1998 Jan; 26(1):149-56. PubMed ID: 9428558
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for disseminated intravascular coagulation in patients with lung cancer.
Nakano K; Sugiyama K; Satoh H; Shiromori S; Sugitate K; Arifuku H; Yoshida N; Watanabe H; Tokita S; Wakayama T; Tatewaki M; Souma R; Koyama K; Hirata H; Fukushima Y
Thorac Cancer; 2018 Aug; 9(8):931-938. PubMed ID: 29851300
[TBL] [Abstract][Full Text] [Related]
33. Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality.
Sawamura A; Hayakawa M; Gando S; Kubota N; Sugano M; Wada T; Katabami K
Thromb Res; 2009 Nov; 124(5):608-13. PubMed ID: 19660788
[TBL] [Abstract][Full Text] [Related]
34. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.
Mosad E; Elsayh KI; Eltayeb AA
Clin Appl Thromb Hemost; 2011 Feb; 17(1):80-7. PubMed ID: 19689998
[TBL] [Abstract][Full Text] [Related]
35. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
[TBL] [Abstract][Full Text] [Related]
36. Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis.
Kim SY; Kim JE; Kim HK; Kim I; Yoon SS; Park S
Blood Coagul Fibrinolysis; 2013 Mar; 24(2):150-6. PubMed ID: 23314386
[TBL] [Abstract][Full Text] [Related]
37. SIRS-associated coagulopathy and organ dysfunction in critically ill patients with thrombocytopenia.
Ogura H; Gando S; Iba T; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Murata A; Ikeda T; Ishikura H; Ueyama M; Kushimoto S; Saitoh D; Endo S; Shimazaki S;
Shock; 2007 Oct; 28(4):411-7. PubMed ID: 17577138
[TBL] [Abstract][Full Text] [Related]
38. Increased soluble fibrin in plasma of patients with disseminated intravascular coagulation.
Wada H; Sase T; Matsumoto T; Kushiya F; Sakakura M; Mori Y; Nishikawa M; Ohnishi K; Nakatani K; Gabazza EC; Shiku H; Nobori T
Clin Appl Thromb Hemost; 2003 Jul; 9(3):233-40. PubMed ID: 14507112
[TBL] [Abstract][Full Text] [Related]
39. Acute Traumatic Coagulopathy: The Value of Histone in Pediatric Trauma Patients.
Ulusoy E; Duman M; Çağlar A; Küme T; Er A; Akgül F; Çitlenbik H; Yılmaz D; Ören H
Turk J Haematol; 2018 May; 35(2):122-128. PubMed ID: 29589832
[TBL] [Abstract][Full Text] [Related]
40. Good or poor responses of hemostatic molecular markers in patients with hematopoietic disorders after treatment of disseminated intravascular coagulation.
Watanabe R; Wada H; Yamamuro M; Inoue A; Watanabe M; Kumeda K; Sakakura M; Okugawa Y; Nakasaki T; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Nobori T; Shiku H
Clin Appl Thromb Hemost; 2003 Jan; 9(1):71-7. PubMed ID: 12643327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
